- Filed
- Nov 6, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 62.43M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 62.12M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 60.42M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 59.85M sh |
| Stock Repurchased | Q3 2025 · Sep 30, 2025 | $172.55M |
| Stock Repurchased | Q3 2025 · Sep 30, 2024 | $0 |
| Dividends Paid | Q3 2025 · Sep 30, 2025 | $143.52M |
| Dividends Paid | Q3 2025 · Sep 30, 2024 | $128.43M |
| Capex | Q3 2025 · Sep 30, 2025 | $358.35M |
| Capex | Q3 2025 · Sep 30, 2024 | $155.81M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | $494.03M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2024 | $493.36M |
| Long Term Debt | Q3 2025 · Sep 30, 2025 | $3.98B |
| Long Term Debt | Q3 2025 · Dec 31, 2024 | $3.39B |
| Cash And Equivalents | Q3 2025 · Sep 30, 2025 | $7.74M |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $3.61M |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | −$1.78B |
| Stockholders Equity | Q3 2025 · Jun 30, 2025 | −$1.57B |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | −$2.98B |
| Stockholders Equity | Q3 2025 · Sep 30, 2024 | −$1.72B |
| Stockholders Equity | Q3 2025 · Jun 30, 2024 | −$1.21B |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | −$530.82M |
| Current Liabilities | Q3 2025 · Sep 30, 2025 | $504.32M |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $418.55M |
| Total Liabilities | Q3 2025 · Sep 30, 2025 | $4.58B |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $3.84B |
| Current Assets | Q3 2025 · Sep 30, 2025 | $315.07M |
| Current Assets | Q3 2025 · Dec 31, 2024 | $294.76M |
| Total Assets | Q3 2025 · Sep 30, 2025 | $7.2B |
| Total Assets | Q3 2025 · Dec 31, 2024 | $6.81B |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | $0.03 |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | $0.41 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | $0.35 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | $1.02 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | $0.03 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | $0.41 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | $0.35 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | $1.03 |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $30.1M |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $91.93M |
| Sga Expense | Q3 2025 · Sep 30, 2024 | $29.62M |
| Sga Expense | Q3 2025 · Sep 30, 2024 | $94.85M |
| Net Income | Q3 2025 · Sep 30, 2025 | $5.27M |
| Net Income | Q3 2025 · Sep 30, 2025 | $35.04M |
| Net Income restated | Q3 2025 · Sep 30, 2024 | $25.76M |
| Net Income restated | Q3 2025 · Sep 30, 2024 | $74.51M |
| Operating Income | Q3 2025 · Sep 30, 2025 | $19.79M |
| Operating Income | Q3 2025 · Sep 30, 2025 | $116.52M |
| Operating Income | Q3 2025 · Sep 30, 2024 | $72.87M |
| Operating Income | Q3 2025 · Sep 30, 2024 | $155.56M |
| Revenue | Q3 2025 · Sep 30, 2025 | $463.97M |
| Revenue | Q3 2025 · Sep 30, 2025 | $1.33B |
| Revenue | Q3 2025 · Sep 30, 2024 | $396.36M |
| Revenue | Q3 2025 · Sep 30, 2024 | $1.1B |